In Situ Bismuth Exsolution‐Driven Controllable Bi/Bi 4 Ti 3 O 12 Heterointerface Catalysts for Enhanced Photocatalytic CO 2 ‐to‐HCOOH Conversion
Angewandte Chemie International Edition · 23.03.2026 · 65 (13)
DOI: 10.1002/anie.4308936 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 15.02.2026. Verfasst von Guojun Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Joint Laboratory of Environment Simulation and Pollution Control, School of Environment, Tsinghua University, Beijing, P.R. China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Postdoctoral Fellowship Program of CPSF, Sinopec Technological Research and Development Projects.
Abstract (Originalsprache)
Heterointerface engineering based on built‐in electric field (BIEF) has emerged as a promising route for regulating interfacial charge transfer and the electronic structure of active sites to achieve efficient photocatalytic CO 2 reduction. However, constructing strongly coupled heterointerfaces to maximize BIEF effects remains challenging. Herein, an off‐equilibrium solvothermal strategy is employed to induce the in situ exsolution of bismuth (Bi) nanoparticles from Bi 4 Ti 3 O 12 , yielding tight and homologous Bi/Bi 4 Ti 3 O 12 (Bi/BTOVs) heterointerface catalysts. Both experimental and theoretical analyses reveal a volcano‐type relationship between the intensity of BIEF and the size of the exsolved Bi nanoparticles. Strengthened BIEF facilitates directional interfacial charge transfer and shifts the Bi p‐band center toward the Fermi level. The optimized p‐band center strengthens the adsorption and activation of CO 2 , thus lowering the formation barrier of the *OCHO intermediate. Moreover, the Bi nanoparticles also induce a localized photothermal effect, raising the reaction temperature to accelerate CO 2 reaction kinetics. As a result, the 8 Bi/BTOVs catalyst with the optimal BIEF achieves a high HCOOH yield of 4126.25 µmol·g −1 ·h −1 with near‐unity selectivity. This study provides a generalizable strategy for the rational design of BIEF‐based strongly coupled heterointerfaces, offering a transferable design principle for photocatalytic CO 2 reduction.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Joint Laboratory of Environment Simulation and Pollution Control, School of Environment, Tsinghua University, Beijing, P.R. China.
- School of Chemistry and Chemical Engineering, Nanjing University of Science and Technology, Nanjing, Jiangsu, P.R. China.
- College of Chemical Engineering, Nanjing Forestry University, Nanjing, P.R. China.
ORCID-Profile: Zhen Chen, Haiwei Su, Shule Zhang, Junhua Li
Förderung
- National Natural Science Foundation of China
- Postdoctoral Fellowship Program of CPSF
- Sinopec Technological Research and Development Projects
Zitieren
APA
Li, G., Chen, Z., Wang, Y., Su, H., Chen, L., Chen, J., Xiao, J., Wang, R., Zhang, S., Zhong, Q., & Li, J. (2026). In Situ Bismuth Exsolution‐Driven Controllable Bi/Bi 4 Ti 3 O 12 Heterointerface Catalysts for Enhanced Photocatalytic CO 2 ‐to‐HCOOH Conversion. Angewandte Chemie International Edition, 65(13). https://doi.org/10.1002/anie.4308936
Vancouver
Li G, Chen Z, Wang Y, Su H, Chen L, Chen J, et al. In Situ Bismuth Exsolution‐Driven Controllable Bi/Bi 4 Ti 3 O 12 Heterointerface Catalysts for Enhanced Photocatalytic CO 2 ‐to‐HCOOH Conversion. Angewandte Chemie International Edition. 2026;65(13). doi:10.1002/anie.4308936
BibTeX
@article{Li2026,
author = {Li, Guojun and Chen, Zhen and Wang, Yunlong and Su, Haiwei and Chen, Lin and Chen, Jianjun and Xiao, Jingrong and Wang, Ruonan and Zhang, Shule and Zhong, Qin and Li, Junhua},
title = {In Situ Bismuth Exsolution‐Driven Controllable Bi/Bi 4 Ti 3 O 12 Heterointerface Catalysts for Enhanced Photocatalytic CO 2 ‐to‐HCOOH Conversion},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {13},
doi = {10.1002/anie.4308936}
}
EUVIMED